Siemens Healthineers has closed its $1.1 billion deal to purchase Corindus Vascular Robotics, a Massachusetts company that manufactures a robotic-assisted platform.
The move is intended to bolster Siemens’ advanced therapies business. The Corindus system is the first FDA-cleared device that combines robotic intervention with percutaneous coronary and vascular procedures.
Corindus’ robotics system lets physicians accurately control guide catheters, guide wires, balloon implants and stent implants through the use of integrated imaging. They can also control the procedure away from the angiography table, so they are less exposed to radiation.